29 related articles for article (PubMed ID: 29224437)
1. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
[TBL] [Abstract][Full Text] [Related]
2. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes.
Willi SM; Miller KM; DiMeglio LA; Klingensmith GJ; Simmons JH; Tamborlane WV; Nadeau KJ; Kittelsrud JM; Huckfeldt P; Beck RW; Lipman TH;
Pediatrics; 2015 Mar; 135(3):424-34. PubMed ID: 25687140
[TBL] [Abstract][Full Text] [Related]
3. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
4. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
6. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
7. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
Abbatecola AM; Bo M; Armellini F; D'Amico F; Desideri G; Falaschi P; Greco A; Guerrini G; Lattanzio F; Volpe C; Paolisso G
Metabolism; 2015 Nov; 64(11):1500-6. PubMed ID: 26318195
[TBL] [Abstract][Full Text] [Related]
8. Challenges in optimal metabolic control of diabetes.
Liebl A
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S36-41. PubMed ID: 12324984
[TBL] [Abstract][Full Text] [Related]
9. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
Davis WA; Bruce DG; Davis TM
Diabetes Care; 2006 Aug; 29(8):1764-70. PubMed ID: 16873777
[TBL] [Abstract][Full Text] [Related]
10. Management of type 2 diabetes: oral agents, insulin, and injectables.
Fonseca VA; Kulkarni KD
J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
[TBL] [Abstract][Full Text] [Related]
11. New oral agents for type II diabetes.
Hollander PA
Postgrad Med; 1995 Dec; 98(6):110-126. PubMed ID: 29224437
[TBL] [Abstract][Full Text] [Related]
12. New oral agents for type II diabetes. Taking a more aggressive approach to therapy.
Hollander PA
Postgrad Med; 1995 Dec; 98(6):110-1, 115-6, 119-21, passim. PubMed ID: 7501573
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
